Premier and 34 Leading Health Systems Partner with DeRoyal to Expand Domestic Production of Isolation Gowns

Premier and 34 Leading Health Systems Partner with DeRoyal to Expand Domestic Production of Isolation Gowns

  • New joint venture will produce isolation gowns in Tennessee, primarily using domestically produced raw materials.
  • Venture is Premier’s second effort to co-invest with health systems in domestic and geographically diverse manufacturers and help ensure that critical healthcare products are insulated from shortages.

CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, and 34 member health systems partnered with DeRoyal Industries Inc., a global medical manufacturer, to create a new joint venture dedicated to the domestic production of isolation gowns.

A new entrant in the market, the joint venture will produce isolation gowns in an existing facility just outside Knoxville, TN. Raw materials will primarily be sourced from U.S.-based manufacturers, with backup capacity from Mexico and South America. In this unique collaboration, gowns are designed to specifications considering the hospital systems’ care delivery requirements, while also allowing for fully automated production that can scale over time. To support the venture long-term, health system co-investors also signed multi-year commitments to purchase a portion of the isolation gowns used each year from the joint venture.

Medical products critical to the daily operations of health systems are overwhelmingly sourced overseas, with approximately 80 percent of PPE coming from Southeast Asia. The risks of this overreliance came into sharp focus as COVID-19 swept across the globe and many nations closed borders and prevented U.S. access to supplies, triggering shortages of PPE needed to protect healthcare workers and the patients they care for. In addition, sourcing from overseas makes replenishment difficult, as it can take 90-120 days for foreign products to reach U.S. shores, depending on country of origin, weather, mode of transportation and customs processes. As a result, approximately 74 percent of U.S. hospitals reported they were unable to source adequate quantities of isolation gowns in the month of April, a problem that has continued as COVID-19 continues to spread.

“Together with our members, Premier has created a proven, replicable co-investment model for generating new sources of supply,” said Premier President Michael J. Alkire. “We rely on a data-driven approach to build more supply chain resiliency, prioritizing investments that will quickly satisfy the greatest needs, at scale. In following this approach, we are protecting providers from shortages, injecting more competition into the market and expanding the GPO portfolio with new domestic and geographically diverse options.”

“Domestic manufacturers face tremendous handicaps against foreign competitors, many of whom draw from among the cheapest labor and supply markets on the planet,” said Brian DeBusk, DeRoyal CEO. “One way we can restore diverse, on-shore and near-shore manufacturing is by investing in automation combined with assurances of long-term purchasing volume at globally competitive prices. With this added certainty, we are now able to move into an entirely new product category, create new American jobs and offer a domestic option for providers where one didn’t exist previously. Our intent is to leverage automation to remain price competitive for the long term.”

The arrangement with DeRoyal is part of Premier’s strategy to create more resiliency in the supply chain. Through this effort, Premier has worked with members to pursue targeted investment opportunities in critical supply categories that lack adequate competition, geographic diversity or stable sources of contingency supply. The first such investment was in Prestige Ameritech, one of the nation’s only domestic producers of face masks and other personal protective equipment (PPE). As a result of the joint investment and a long-term commitment to purchase products from Prestige Ameritech, the company is now making 3.5 million additional N95 masks per month for U.S. healthcare providers. Moving forward, Premier plans to address critical supply needs through similar partnerships with members in other product categories, including gloves and disinfecting wipes.

Premier members participating in the initial investment include, among others: AdventHealth (Altamonte Springs, FL), Atrium Health (Charlotte, NC), Baptist Health (Louisville, KY), Beebe Healthcare (Lewes, DE), CHAMPS GPO (Cleveland, OH), Chesapeake Regional Healthcare (Chesapeake, VA), Med Center Health (Bowling Green, KY), Community Medical Centers (Fresno, CA), East Alabama Medical Center (Opelika, AL), First Health of the Carolinas (Pinehurst, NC), Health Enterprise Cooperative (Cedar Rapids, IA), Henry Ford Health System (Detroit, MI), Hospital for Special Surgery (New York, NY), McLaren Health Care (Grand Blanc, MI), Methodist Health System (Dallas, TX), Mon Health System (Morgantown, WV), Monument Health (Rapid City, SD), Norton Healthcare (Louisville, KY), OSF HealthCare (Peoria, IL), Riverside Health System (Newport News, VA), SBH Health System (New York, NY), St. Elizabeth Healthcare (Edgewood, KY), St. Luke’s University Health Network, (Bethlehem, PA), The University of Tennessee Medical Center (Knoxville, TN), Texas Health Resources (Arlington, TX) and University of Virginia Medical Center (Charlottesville, VA).

Revenues from the investment in the joint venture are not expected to materially impact Premier FY 2021 results.

Gowns produced by the new joint venture are expected to be available in mid-2021.

About Premier Inc.

Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals and health systems and approximately 200,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.

About DeRoyal Industries, Inc.

DeRoyal is a 47-year old family-owned business with over 25,000 products including orthopedic devices, surgical accessories, and wound care supplies. The company has approximately 2,000 employees in 21 locations on three different continents, with the majority of its production capacity residing inside the continental United States. DeRoyal has been a pioneer in the reshoring of medical devices beginning with its plastics division in 1985 and expanding into other manufacturing disciplines throughout the following decades. Please visit www.deroyal.com for more information.

Amanda Forster

[email protected]

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Supply Chain Management Medical Supplies Retail Health Hospitals Other Health

MEDIA:

Logo
Logo

Global Warming Solutions Inc. Announces the Addition of Three Leading Industry Members to its Advisory Committee.

Jacksonville, FL, Nov. 16, 2020 (GLOBE NEWSWIRE) — Global Warming Solution Inc., (OTC MARKETS: GWSO), is pleased to announce that effective today, three new members were added to it’s Advisory Committee. Prof. Robert F. Waters, Ph.D., Del Bentz M.S. and Bret W. Rawson brings decades of valuable leadership to Global Warming Solutions, Inc. 

About Prof. Robert F. Waters

Prof. Robert F. Waters, Ph.D. is a senior research professor at Arizona State University Biodesign Institute. He is co-developer of many successful anti-cancer and anti-viral treatments. His research includes focus in genomics, anti-virals, diabetes, cancer, artificial intelligence, and mathematics. He also continues to be published in major journals, and attends speaking engagements regularly.

Prof. Robert F. Waters is a current member of the Mathematical Association of America, and the American College of Medical Genetics (Emeritus Status).

Service in Organizations

  • Kansas State University working on DNA Hybridization techniques
  • CYMMYT (Mexico) under the auspices of Nobel Prize Laureate, Prof. Norman E. Borlaug.
  • CAPLAMAR (Mexico City), CIA (Langley), British Petroleum (London), and Tyndall AFB (Florida), working on CIS WAN communications.
  • Worked with the State of Arizona on the “Seatbelt Coalition,” and Arizona State Educational statistics issues.
  • 20 years in medical schools, and continues to teach Medical Biochemistry, Medical Genetics, and Biostatistics.

About Del Bentz M.S.

Del Bentz is the first engineer to have developed a unique feedback control system that achieves high-speed robotic movement with precise control and has won a national award for innovation in controls. He worked as an engineer in the space industry, and helped in developing the most efficient brushless DC motor of its time.

Del Bentz is one of several researchers who discovered a new method of processing an ancient plant material into soil stimulating products. This has formulated health products for both animals, and humans that can also be utilized as nontoxic natural pest control products for humans, crops, animals, and fish. These products have been granted several patents and national awards for innovative product and design.

His other accomplishments include:

  • Development of new product lines for wastewater, plants and soil, which has shown to out perform all current known products of its type. (This is currently being introduced around the world).
  • Proven water savings up to 40% in desert conditions with the Salt River Project 1/2.
  • Developed products to provide plant minerals for human health. Developed the technology for the extraction of ancient plant material from a compound called Fulvic acid known as the “miracle molecule of health.”
  • Currently working with innovative products for aqua-culture for the extraction of sea lice on salmon. Awarded a patent for the formulation of this product. This product has been proven to out perform all other current products on the market (waiting for a government license to market this to the fish industry).
  • Developed a nontoxic product for head lice on children. Tested successfully and currently used by doctors and nurses in homeless shelters around the Phoenix (Arizona)  area.
  • Currently developing the Ballast Water Treatment system for the sterilization of ballast water. Jointly patented this process using a new mechanism for the destruction of bacteria, viruses, and spores for the use in water sterilization. (The UN has mandated that all seawater used as ballast, must meet certain water standards so that no cross contamination can occur). This patented technology is the lowest cost system on the market at this time.. Waiting for funding to finish product testing.
  • Developing a passive water sterilization system to produce biologic free fresh water for people who live in 3rd world countries.

About
Bret W. Rawson

Bret Rawson is a General Counsel for the Utah Fraternal Order of Police, that represents more than 4,000 law enforcement officers and is a subordinate lodge of the largest police fraternal organization in the United States, the National Fraternal Order of Police, with membership exceeding 350,000.

Mr. Rawson is also a Board Member of the Wounded Blue, a non-profit organization aimed at supporting catastrophically-injured law enforcement officers.

Mr. Rawson’s practice focuses on police concerns that include administrative matters regarding Peace Officer Standards and Training (POST) as well as internal affairs and officer-involved critical incidents.

Mr. Rawson is also a reserve police officer at a local Utah municipality. Mr. Rawson holds a JD from the Marshall-Wythe School of Law at the College of William & Mary in Virginia, and a master’s degree in mass communication from Brigham Young University in Provo, Utah.

“I couldn’t be more pleased to have so much talent under one roof to guide the company’s success. We are very thrilled to welcome Prof. Waters, Dr. Bentz and Mr. Rawson.” said Vladimir Vasilenko, Chief Executive Officer of Global Warming Solutions. “Their professional background and expertise will be an integral part of our projects.”

‘We will be announcing more great minded advisors to join the committee as well as key management shortly. Based on the high demand for the company’s products, we will also be adding a sales force  to ensure growth.”
As related to financial aspects, we expect to receive a clearance to file the company’s audited financials within the next 24 hours.” concluded Vladimir Vasilenko.

To learn more about Global Warming Solutions, Inc. Visit: http://www.gwsogroup.com

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at https://www.gwsogroup.com.

Contact:
Vladimir Vasilenko
CEO
Global Warming Solutions, Inc.
[email protected]



Survey: Pandemic Has Cost-Conscious Consumers Reevaluating Everything From Holiday Spending to Health Insurance

MOUNTAIN VIEW, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — The COVID-19 pandemic has Americans reevaluating everything from holiday shopping and health insurance, to whether they will see family in person for Thanksgiving according to a new healthinsurance.com national survey conducted by Scott Rasmussen.

Key Takeaways:

  • 41% are experiencing “pandemic fatigue;”
  • 59% plan to spend Thanksgiving in person with their family;
  • 78% are more likely to support small businesses and buy local this year;
  • 40% plan to spend less on gifts this year compared to other years;
  • 63% would pay less, if they could change one thing about their current health insurance plan.

ENGAGING IN OPEN ENROLLMENT 2020

As open enrollment is underway from now until December 15th, 83% say they are happy with their current health insurance coverage, yet 50% are exploring their options. 28% of those surveyed said they are likely to change their coverage this open enrollment period with an additional 22% admitting they are still undecided. Of the 17% that aren’t happy with their current coverage, 55% say it’s because not enough benefits are covered.

When asked if there was one thing respondents would change about their current health insurance, 63% cited cost issues:

  • 30% said lower premiums;
  • 26% more coverage and benefits;
  • 16% lower deductibles;
  • 11% doctor networks;
  • 10% lower copays;
  • 7% prescription drug costs.

PANDEMIC PAUSING ONLY SOME IN-PERSON HOLIDAY PLANS

The COVID-19 pandemic is taking an emotional toll on many Americans; 4 in 10 say they are experiencing “pandemic fatigue.” When asked about attending in-person gatherings of close friends and family right now, 63% said they are comfortable. Which is in line with the 59% who said they intend on spending Thanksgiving in person with their family. Of the 41% who said no or still unsure about their Thanksgiving plans, the reasons were:

  • 50% COVID-19 concerns;
  • 12% COVID-19 travel restrictions;
  • 7% are using COVID-19 as an excuse so they don’t have to talk politics with relatives;
  • 30% said it’s because they rarely spend time with family.

Additionally, some are having a techie turkey day dinner, 20% are planning a virtual Thanksgiving dinner.

HOLIDAY SHOPPING TRENDS DURING A HEALTH PANDEMIC

The pandemic is influencing shopping behavior heading into the holiday season. Getting into the holiday spirit, 78% say they are more likely to support small businesses and buy local this year. 57% don’t plan to shop in person on Black Friday this year, with an additional 16% still undecided. 35% said they plan to shop only online this holiday season, while 47% are planning to do a combo of online and in person shopping. Unfortunately it’s not all joyful finding: 40% say they plan to spend less on gifts this year compared to other years.

For the entire survey results click here

METHODOLOGY:

The survey of 1,000 Adults was conducted by Scott Rasmussen using a mixed mode approach from November 6-10, 2020. Field work for the survey was conducted by RMG Research, Inc. Most respondents were contacted online or via text while 112 were contacted using automated phone polling techniques. Certain quotas were applied to the overall sample and lightly weighted by geography, gender, age, race, education, and political party to reasonably reflect the nation’s population of Registered Voters. Other variables were reviewed to ensure that the final sample is representative of that population.

ABOUT HEALTHINSURANCE.COM:

Healthinsurance.com combines the nation’s leading health insurance carriers and advanced technology to offer a suite of private insurance solutions and Medicare plan options. In just a few clicks, our website provides consumers the ability to access powerful online comparison tools and educational resources that enable efficient self-guided navigation of available health insurance and Medicare options. For more information, visit www.healthinsurance.com.

A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/98703a1d-36dd-4575-aa30-0f8421dd3714



For More Information:
Media Contact:
Jennifer Seelig
[email protected] 

Investor Contact:
Benefytt Technologies, Inc.:
Mike DeVries
Chief Financial Officer
[email protected]

FSIS ISSUES PUBLIC HEALTH ALERT FOR CHICKEN AND PORK TAMALES CONTAINING FDA-REGULATED DICED TOMATOES IN PUREE THAT HAVE BEEN RECALLED DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION

Washington, DC, Nov. 15, 2020 (GLOBE NEWSWIRE) —

  

                                                                     

Public Health Alert
  Congressional and Public Affairs
Maria Machuca (202) 720-9113

[email protected]

 

FSIS ISSUES PUBLIC HEALTH ALERT FOR CHICKEN AND PORK TAMALES CONTAINING FDA-REGULATED DICED TOMATOES IN PUREE THAT HAVE BEEN RECALLED DUE TO POSSIBLE FOREIGN MATTER CONTAMINATION

 

 

WASHINGTON, Nov. 15, 2020 – The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for ready-to-eat (RTE) chicken and pork tamale products containing Food and Drug Administration (FDA) regulated diced tomatoes in puree that have been recalled by the producer, due to concerns that the products may be contaminated with extraneous materials, specifically hard plastic. The hard plastic may pose a choking hazard or cause damage to teeth or gums. FSIS is issuing this public health alert out of the utmost of caution to ensure that consumers are aware that these products, which bear the USDA mark of inspection, should not be consumed.

 

The frozen RTE chicken and pork tamale items were produced between Oct. 22, 2020 and Nov. 9, 2020 by Tucson Tamale Wholesale Co. LLC, an establishment in Tucson, Ariz.  The following products are subject to the public health alert:

 

  • Cases containing eight individually packed tamales with the labels “TUCSON TAMALE GREEN CHILE CHICKEN TAMALE” or “TUCSON TAMALE Green Chile Chicken Tamales” with lot codes F20296 and F20309 and sell by dates of 10/23/22 and 11/05/22.
  • Cases containing six packages with two tamales each of “TUCSON TAMALE GREEN CHILE CHICKEN TAMALES” with lot codes F20309 and F20296 and sell by dates of 10/23/22 and 11/05/22.
  • Cases containing 30 tamales of “TUCSON TAMALE Green Chile Pork & Cheese Tamales” with lot codes F20303 and F20307 and sell by dates of 10/30/22 and 11/03/22.
  • Cases containing eight individually packed tamales of “TUCSON TAMALE GREEN CHILE PORK & CHEESE TAMALE” with lot codes F20307 and F20314 and sell by dates of 11/03/22 and 11/10/22.
  • Cases containing six packages with two tamales each of “TUCSON TAMALE GREEN CHILE PORK & CHEESE TAMALES” with lot codes F20303 and F20307 and sell by dates 10/30/22 and 11/03/22.
  • Packages containing two tamales of “TUCSON TAMALE GREEN CHILE PORK & CHEESE TAMALES” with lot codes F20303, F20307 and F20302 and sell by dates of 10/29/22, 10/30/22 and 11/03/22.
  • Cases containing 30 tamales of “TUCSON TAMALE Green Chile Chicken Tamales” with lot code F20296 and sell by date of 10/23/22.

 

The products bear establishment number “EST. 45860” inside the USDA mark of inspection. These items were sold online and also shipped to distributors for further distribution to retail locations and restaurants nationwide.

 

The problem was discovered by Tucson Tamale Wholesale Co. when they identified pieces of hard plastic in the cans of diced tomatoes in puree that they received from their ingredients supplier. The ingredients supplier initiated a recall of the diced tomatoes in puree with the FDA. As more FDA information becomes available, FSIS will update this public health alert.

 

There have been no confirmed reports of adverse reactions due to consumption of these products. Anyone concerned about an illness should contact a health care provider.

 

 FSIS is concerned that some product may be in consumers’ freezers. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.

 

Consumers and members of the media with questions can contact Sherry Martin, CEO of Tucson Tamale Wholesale Co., at (520) 398-6282.

 

Consumers with food safety questions can call the toll-free USDA Meat and Poultry Hotline at 1-888-MPHotline (1-888-674-6854) or live chat via Ask USDA from 10 a.m. to 6 p.m. (Eastern Time) Monday through Friday. Consumers can also browse food safety messages at Ask USDA or send a question via email to [email protected]. For consumers that need to report a problem with a meat, poultry, or egg product, the online Electronic Consumer Complaint Monitoring System can be accessed 24 hours a day at https://foodcomplaint.fsis.usda.gov/eCCF/.

 

 

###
NOTE: Access news releases and other information at FSIS’ website at http://www.fsis.usda.gov/recalls.

Follow FSIS on Twitter at twitter.com/usdafoodsafety or in Spanish at: twitter.com/usdafoodsafe_es.

 

USDA is an equal opportunity provider, employer and lender. To file a complaint of discrimination, write: USDA, Director, Office of Civil Rights, 1400 Independence Avenue, SW, Washington, DC 20250-9410 or call (800) 795-3272 (voice), or (202) 720-6382 (TDD). 

         
         



USDA FSIS
USDA Food Safety and Inspection Service
[email protected]

CMIC Supports Clinical Trials for Digital Therapeutics Using SUSMED’s Trial Management System

CMIC Supports Clinical Trials for Digital Therapeutics Using SUSMED’s Trial Management System

TOKYO–(BUSINESS WIRE)–
CMIC Co., Ltd. (henceforth “CMIC”)(TOKYO:2309) has launched services using SUSMED, Inc.’s (henceforth “SUSMED”) trial management system covering subject registration, software assignment and distribution for digital therapeutics (DTx).

The system is able to overcome the common challenges of DTx clinical trials, ensuring blinded assignment and preventing unauthorized access. By employing this system, CMIC will offer more efficient operations for DTx trials, such as for the assignment and delivery of software applications (apps) to trial participants, cutting development costs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201115005172/en/

*The system allows for seamless management of both intervention/sham app assignment and app distribution. (Graphic: Business Wire)

*The system allows for seamless management of both intervention/sham app assignment and app distribution. (Graphic: Business Wire)

In a DTx clinical trial, the software app must be installed on a device, such as a smartphone. Additionally, a placebo app (sham) is often used as a control in comparison to the actual treatment app (intervention), so it is essential that each app is correctly distributed to each patient, as assigned. For this reason, many processes and tasks differ from general drug development, such as loaning pre-installed, study-specific devices to trial subjects. This results in a heavy burden on companies developing DTx. Furthermore, because everything from assignment to patient distribution is done digitally, it is vital to take security measures in order to prevent any unauthorized access.

When using SUSMED’s system, each patient will be registered in a secure environment, and an app (intervention or sham) will be assigned to each patient with a specific ID. The patient can start his or her assigned treatment by installing the app using the issued ID. As this ID-assignment function allows patients to install their assigned app to their personal device, device rental is unnecessary, cutting development costs significantly. In addition, higher quality data and treatment compliance is expected because patients are already familiar with their own device.

Making the most out of the system’s features, CMIC will effectively complete each DTx clinical trial by formulating the best distribution strategies for each therapeutic intervention.

“We have developed this service as an extension of the strategic partnership with SUSMED that we announced on October 21st this year. By introducing SUSMED’s trial management system, we hope to overcome some of the security and cost challenges of DTx development. We will continue to promote open innovation and the growth of the DTx market, in order to answer the needs of clients, healthcare providers and patients, as soon as possible.” said Toru Fujieda, President of CMIC Co., Ltd.

“Since its founding, SUSMED has developed new technology in order to achieve sustainable medicine through ICT. There are several challenges in DTx development that differ from drug development. By providing this trial management system, we hope to contribute to faster and more efficient development of DTx. We will continue to contribute to the growth of DTx by combining SUSMED’s technology and CMIC’s comprehensive clinical trial services.” said Taro Ueno, CEO of SUSMED, Inc.

To learn more about this service, please contact us at [email protected]

About CMIC group

CMIC Group was founded in 1992 as the first Contract Research Organization (CRO) in Japan. Today CMIC Group is the largest clinical CRO in Japan with global footprint, providing comprehensive services in drug development, clinical site management, clinical to commercial GMP manufacturing, regulatory consulting and contract sales & marketing solutions. We can help pharmaceutical, biotech and medical device companies to enter Japan market, to conduct clinical trials in Asia, or to bridge drug development and manufacturing needs in the US, Europe, Japan and broader Asia. CMIC Group has over 7,000 employees and 25 sites globally. For more information about CMIC Group and services, please visit our website.

https://en.cmicgroup.com/

About SUSMED, Inc.

SUSMED Inc., is a research and development firm that is working to advance digital therapies. In addition to developing an app for treating insomnia, SUSMED provides a universal platform for developing medical apps, along with clinical trial support systems and automated AI analysis systems. SUSMED is advancing digital therapy grounded in technology, with patents in medical apps and blockchain applications in medical treatment.

https://www.susmed.co.jp/en

 

CMIC HOLDINGS Co., LTD.

PR group

Yuko Ishikawa

E-mail: [email protected]

SUSMED, Inc.

E-mail: [email protected]

KEYWORDS: Japan Asia Pacific

INDUSTRY KEYWORDS: Health Technology Mobile/Wireless Software Clinical Trials Pharmaceutical

MEDIA:

Logo
Logo
Photo
Photo
*The system allows for seamless management of both intervention/sham app assignment and app distribution. (Graphic: Business Wire)
Logo
Logo

Great Elm Capital Group, Inc. Reports First Fiscal Quarter 2021 Financial Results

  • DME fiscal Q1 revenue grew 10.4% year-over-year and 5.0% sequentially highlighting the business’ ability to grow despite the negative impact from COVID-19 on new equipment rental set-ups
  • DME fiscal Q1 net loss of $0.5 million improved from a net loss of $0.8 million year-over-year while adjusted EBITDA of $2.8 million decreased from $3.0 million primarily reflecting the incremental costs of operating during the pandemic
  • Investment Management is poised for growth in AUM, revenue, and earnings following the successful completion of the $31.7 million GECC rights offering

WALTHAM, Mass., Nov. 15, 2020 (GLOBE NEWSWIRE) — Great Elm Capital Group, Inc. (NASDAQ: GEC, “Great Elm”) announced its financial results for the quarter ended September 30, 2020. Great Elm will host a conference call and webcast on Monday, November 16, 2020 at 8:00 a.m. Eastern Time to discuss its first fiscal quarter 2021 financial results. Please see below for details.

Select highlights from the first quarter 2021 include:

  • Operating Companies:

▪ For the three months ended September 30, 2020, $14.6 million of revenue, $0.5 million of net loss and $2.8 million of adjusted EBITDA
▪ Having completed significant investments into the platform, DME management is focused on continuing organic growth, driving improved margins, and making add-on acquisitions
▪ New PAP patient setups declined 24.7% year over year but increased sequentially 2.8% as the business recovers from the effects of the COVID-19 pandemic 

  • Investment Management:

▪ For the three months ended September 30, 2020, $0.8 million of revenue, net loss of $0.1 million and $0.2 million of adjusted EBITDA
▪ Great Elm Capital Corp. (“GECC”), managed by our wholly owned subsidiary, Great Elm Capital Management, Inc. (“GECM”), raised gross proceeds of $31.7 million through the completion of a rights offering.
▪ GEC purchased approximately 3.0 million shares in the offering for $8.8 million

“We made significant progress toward the achievement of our strategic goals for both our DME and Investment Management businesses during the quarter, ” remarked Peter A. Reed, Great Elm’s Chief Executive Officer. “DME added key management talent, continued to improve operationally and is actively pursuing attractive add-on acquisition opportunities.  For Investment Management, not only will the successful rights offering at GECC enable the pursuit of attractive acquisitions in the specialty finance sector, it enhances GECM’s revenue, earnings and cash flow potential which ultimately benefits our shareholders.”      

Alignment of Interest

The employees and directors of Great Elm and GECM collectively own or manage 7.1 million shares or approximately 27% of Great Elm’s outstanding shares.

FINANCIAL REVIEW: SEGMENT FINANCIALS

As of September 30, 2020, Great Elm had four operating segments: Durable Medical Equipment, Investment Management, Real Estate and General Corporate.


Durable Medical Equipment

Three Months Ended September 30, 2020:

Revenue:

  • During the three months ended September 30, 2020, Great Elm recognized $14.6 million in total revenue vs. $13.2 during the same period in the prior year.

Net Income (Loss):

  • During the three months ended September 30, 2020, Great Elm recognized a net loss of $0.5 million vs. $0.8 million of net loss during the same period in the prior year.

Adjusted EBITDA:

  • During the three months ended September 30, 2020, Great Elm recognized $2.8 million in adjusted EBITDA vs. $3.0 million during the same period in the prior year.

Commentary:

  • During the quarter, PAP supply sales remained strong while rental revenues continued to be negatively impacted by suppressed referral pipelines for new equipment set-ups during the pandemic.  We remain intently focused on exploring ways to lower DME’s cost of capital and obtaining additional funds for potential future acquisitions.


Investment Management

Three Months Ended September 30, 2020:

Revenue:

  • During the three months ended September 30, 2020, Great Elm recognized total investment management revenue of $0.8 million vs. $0.9 million during the same period in the prior year.

Net Income (Loss):

  • During the three months ended September 30, 2020, Great Elm recognized a net loss of $0.11 million vs. a net loss of $0.05 million during the same period in the prior year.

Adjusted EBITDA:

  • During the three months ended September 30, 2020, Great Elm recognized adjusted EBITDA of $0.2 million vs. $0.4 million during the same period in the prior year.

Commentary:

  • During the quarter, GECC benefitted from strong performance of its specialty finance investments, the redeployment of funds into attractive risk-adjusted opportunities and the rebounding of the valuations of certain of its investments following COVID related volatility in the prior quarter.  Great Elm intends to continue to focus on attractive acquisition opportunities in the specialty finance sector going forward.


Real Estate

Three Months Ended September 30, 2020:

Revenue:

  • During the three months ended September 30, 2020, Great Elm recognized $1.3 million in rental revenue vs. $1.3 million during the same period in the prior year.

Net Income (Loss):

  • During the three months ended September 30, 2020, Great Elm recognized $0.1 million in net income vs. $0.1 million in net income during the same period in the prior year.

Adjusted EBITDA:

  • During the three months ended September 30, 2020, Great Elm recognized $1.1 million in adjusted EBITDA vs. $1.1 million during the same period in the prior year.

Commentary

  • Great Elm continues to manage the Fort Myers investment to monetize significant net operating loss carryforwards.


General Corporate

Three Months Ended September 30, 2020:

Revenue:

  • During the three months ended September 30, 2020, Great Elm recognized $0.09 million in revenue vs. $0.02 million in revenue during the same period in the prior year.

Net Income (Loss):

  • During the three months ended September 30, 2020, Great Elm recognized $3.4 million in net loss vs. net loss of $2.5 million during the same period in the prior year.

Adjusted EBITDA:

  • During the three months ended September 30, 2020, Great Elm recognized $(1.1) million in adjusted EBITDA vs. $(1.7) million during the same period in the prior year.

Commentary:

  • During the quarter, Great Elm made significant progress on reducing its corporate overhead, driven largely by a reduction in audit cost.  Great Elm intends to continue to focus on reducing its corporate overhead going forward.

Conference Call & Webcast

Great Elm will host a conference call and webcast on Monday, November 16, 2020 at 8:00 a.m. Eastern Time to discuss its first quarter 2021 financial results.

All interested parties are invited to participate in the conference call by dialing +1 (844) 559-0750; international callers should dial +1 (647) 689-5386. Participants should enter the Conference ID 4790827 when asked. For a copy of the slide presentation that will be referenced during the course of our conference call, please visit: https://www.greatelmcap.com/events-and-presentations/default.aspx.

The conference call will be webcast simultaneously at: https://event.on24.com/wcc/r/2625162/1D4EAD6DA2778005450B2AF1E04864A3 [event.on24.com]

About Great Elm Capital Group, Inc.

Great Elm is a publicly-traded holding company that seeks to build a business across two operating verticals: Operating Companies and Investment Management. Great Elm’s website can be found at www.greatelmcap.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release that are “forward-looking” statements, including statements regarding revenue, adjusted EBITDA, expected growth, profitability, free cash flow and outlook involve risks and uncertainties that may individually or collectively impact the matters described herein. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made and represent Great Elm’s assumptions and expectations in light of currently available information.  These statements involve risks, variables and uncertainties, and Great Elm’s actual performance results may differ from those projected, and any such differences may be material. For information on certain factors that could cause actual events or results to differ materially from Great Elm’s expectations, please see Great Elm’s filings with the SEC, including its most recent annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. Additional information relating to Great Elm’s financial position and results of operations is also contained in Great Elm’s annual and quarterly reports filed with the SEC and available for download at its website www.greatelmcap.com or at the SEC website www.sec.gov.

Non-GAAP Financial Measures

The SEC has adopted rules to regulate the use in filings with the SEC, and in public disclosures, of financial measures that are not in accordance with US GAAP, such as adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”). Adjusted EBITDA is derived from methodologies other than in accordance with US GAAP. Great Elm believes that Adjusted EBITDA is an important measure for investors to use in evaluating Great Elm’s businesses. In addition, Great Elm’s management reviews Adjusted EBITDA as they evaluate acquisition opportunities.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it either in isolation from, or as a substitute for, analyzing Great Elm’s results as reported under US GAAP. Non-GAAP financial measures reported by Great Elm may not be comparable to similarly titled amounts reported by other companies.

Set forth below is a reconciliation of Adjusted EBITDA to the most directly comparable US GAAP financial measure, net income. The information in the table below represents Great Elm’s assumptions and expectations in light of currently available information. Great Elm’s actual performance results may differ from those projected in in the table below, and any such differences may be material.

     For the three months ended September 30, 2020 
$ in thousands   DME     Investment Management     Real Estate     General Corporate     Consolidated  
EBITDA:                              
Net income (loss) – GAAP   $                (458 )   $                (107 )   $                    67     $             (3,365 )   $             (3,863 )
Interest expense   709     26     650     572     1,957  
Depreciation & Amortization   2,211     128     430         2,769  
Tax expense               99     99  
EBITDA   $               2,462     $                    47     $               1,147     $             (2,694 )   $                  962  
Adjusted EBITDA                              
Stock based compensation       194         235     429  
GECC dividend income               (524 )   (524 )
GECC Unrealized (gains) / losses               1,902     1,902  
Other (income) expense   3             (1 )   2  
Transaction and integration costs 2   112             33     145  
Severance   27                 27  
Location start up expense   54                 54  
DME management and monitoring fees   116             (91 )   25  
Adjusted EBITDA   $               2,774     $                  241     $               1,147     $             (1,140 )   $               3,022  
     For the three months ended September 30, 2019 
                               
                               
$ in thousands   DME     Investment Management

1
    Real Estate     General Corporate     Consolidated  
EBITDA:                              
Net income (loss) – GAAP   $                (819 )   $                  (45 )   $                    60     $             (2,474 )   $             (3,278 )
Interest expense   996     42     658         1,696  
Depreciation & Amortization   2,508     179     431         3,118  
Tax expense               242     242  
EBITDA   $               2,685     $                  176     $               1,149     $             (2,232 )   $               1,778  
Adjusted EBITDA                              
Stock based compensation       175         118     293  
Change in contingent consideration 2               (195 )   (195 )
Dividend income from GECC               (490 )   (490 )
GECC Unrealized (gains) / losses               983     983  
Other (income) expense   (3 )               (3 )
Transaction and integration costs 2   148             120     268  
Severance   2                 2  
Location start up expense   135                 135  
                               
                               
DME management and monitoring fees   48             (23 )   25  
Adjusted EBITDA   $               3,015     $                  351     $               1,149     $             (1,719 )   $               2,796  

(1)   Prior year non-GAAP adjustments have been updated to conform to current year presentation by removing adjustments associated with the adoption of ASC 606 Contracts with Customers.
     
(2)   Transaction and integration related costs include costs to acquire and integrate acquired businesses.  This also represents change in contingent consideration liability since the initial valuation at the acquisition date.
     

Media & Investor Contact:

Investor Relations
+1 (617) 375-3006
[email protected]



NIKOLA 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Nikola Corporation – NKLA, NKLAW, f/k/a VectoIQ Acquisition Corp. VTIQ, VTIQW, VTIQU

PR Newswire

NEW ORLEANS, Nov. 15, 2020 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until November 16, 2020 to file lead plaintiff applications in securities class action lawsuits against Nikola Corporation (NasdaqGS: NKLA, NKLAW) f/k/a VectoIQ Acquisition Corp. (NasdaqCM: VTIQ, VTIQW, VTIQU), if they purchased the Company’s securities between March 3, 2020 and October 15, 2020, inclusive (the “Class Period”) or owned VectoIQ shares as of the May 8, 2020 record date and were entitled to vote on VectoIQ’s proposed transaction with Nikola.  These actions are pending in the United States District Courts for the District of Arizona, Eastern District of New York and Central District of California.

What You May Do

If you purchased securities of Nikola or VectoIQ as above and would like to discuss your legal rights and how these cases might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-nkla  to learn more. If you wish to serve as a lead plaintiff in these class actions by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by November 16, 2020.

About the Lawsuit

Nikola and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On September 10, 2020, Hindenburg Research published a report alleging that evidence showed the Company was “an intricate fraud built on dozens of lies.”  Subsequently, it was reported that the Company was the subject of probes by both the U.S. Securities and Exchange Commission and the Justice Department. Then, on September 21, 2020, the Company announced the sudden resignation of Founder and Executive Chairman, Trevor Milton. Then, in several interviews on October 15-16, 2020, the Company’s CEO made statements indicating that the Company’s strategic manufacturing partnership with General Motors could fall through.

On this news, the price of Nikola’s shares plummeted.

The first-filed case is Borteanu v. Nikola Corporation et al., 20-cv-01797.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected] 
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/nikola-24-hour-deadline-alert-former-louisiana-attorney-general-and-kahn-swick–foti-llc-remind-investors-with-losses-in-excess-of-100-000-of-deadline-in-class-action-lawsuits-against-nikola-corporation—nkla-nklaw-fka-ve-301173202.html

SOURCE Kahn Swick & Foti, LLC

BEST Inc. Announces Wind Down of BEST Store+ and Management Change to Increase Focus on Core Businesses

PR Newswire

HANGZHOU, China, Nov. 15, 2020 /PRNewswire/ — BEST Inc. (NYSE: BEST) (“BEST” or the “Company”), a leading integrated smart supply chain solutions and logistics services provider in China, today announced that it will begin to wind down its BEST Store+ (“Store+“) business.

The Company believes that by phasing out Store+, it can eliminate the significant cashflow requirements associated with this early stage business, allowing the Company to further prioritize capital allocation towards its core businesses.

The Company expects to cease all operations of Store+ by the end of the year except for the self-operated WoWo convenience stores, which the Company plans to continue running while evaluating various strategic options. The online merchandise sourcing and store management platform will be handed over to independent third parties for continued operations.

“Store+ provided a creative solution for last-mile delivery and empowered many small merchants to participate in online-to-offline commerce,” said Johnny Chou, Chairman and Chief Executive Officer of BEST Inc. “Over the past several quarters, Store+ has been making encouraging progress in reducing losses. However, as we continue to deploy capital towards our core businesses in order to strengthen our position in the increasingly competitive market environment, we concluded that phasing out Store+ is in the best interest of our Company as a whole and in line with our commitment to sustainable profitability and enhancing shareholder value.”  

In addition, the Company announced a management change to BEST Express. Effective as of the date of this announcement, Mr. Shaohua Zhou will cease his role as Senior Vice President, General Manager of BEST Express, and take up a new role as special assistant to Mr. Johnny Chou. Mr. Xiaoqing Wang will assume the position of Vice President, General Manager of BEST Express.

Prior to taking up the new role, Mr. Wang had been General Manager of BEST’s Jiangsu province branch since 2009, spearheading BEST Express and other service lines in Jiangsu province, China. From 2004 to 2009, Mr. Wang was senior sales manager of the Nanjing branch of UTStarcom China. Mr. Wang received a bachelor’s degree in economics and management from Nanjing Agricultural University and an EMBA degree from the University of Texas.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the business outlook and quotations from management in this announcement, as well as BEST’s strategic and operational plans, contain forward-looking statements. BEST may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about BEST’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: BEST’s goals and strategies; BEST’s future business development, results of operations and financial condition; BEST ‘s ability to maintain and enhance its ecosystem; BEST ‘s ability to continue to innovate, meet evolving market trends, adapt to changing customer demands and maintain its culture of innovation; fluctuations in general economic and business conditions in China and other countries in which BEST operates, and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in BEST’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and BEST does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

About BEST Inc.

BEST Inc. (NYSE: BEST) is a leading integrated smart supply chain solutions and logistics services provider in China. Through its proprietary technology platform and extensive networks, BEST offers a comprehensive set of logistics and value-add services, including express and freight delivery, supply chain management and last-mile services, truckload service brokerage, international logistics and financial services. BEST’s mission is to create a smarter, more efficient supply chain in the new retail era by leveraging technology and business model innovation. For more information, please visit: http://www.best-inc.com/en/.  

Investor and Media Contacts

BEST Inc.
Investor Relations Team
E-mail: [email protected]

The Piacente Group, Inc.
Yang Song
Tel: +86-10-6508-0677
E-mail: [email protected]

The Piacente Group, Inc.
Brandi Piacente
Tel: +1-212-481-2050
E-mail: [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/best-inc-announces-wind-down-of-best-store-and-management-change-to-increase-focus-on-core-businesses-301173205.html

SOURCE BEST Inc.

Zeavola Resort Has Signed up to UNESCO’s Sustainable Tourism Pledge, as One of the First Hotels in Thailand

Zeavola Resort Has Signed up to UNESCO’s Sustainable Tourism Pledge, as One of the First Hotels in Thailand

TOKYO–(BUSINESS WIRE)–
Wedge Holdings is pleased to announce that the Zeavola Resort, a luxury resort owned by our Group and located on the island of Phi Phi Phi, Thailand, was one of the first hotels to sign up to the United Nations Educational, Scientific and Cultural Organization’s (UNESCO) Sustainable Tourism Pledge (a pledge on sustainable travel) and has been officially accredited and featured on the UNESCO website.

The Sustainable Tourism Pledge is an initiative by UNESCO, in cooperation with the Tourism Authority of Thailand (TAT) and Expedia Group, to promote sustainable tourism and the conservation of world heritage sites, and is scheduled to be rolled out globally, starting with Thailand. Member hotels that operate in an environmentally friendly manner will make it clear that they are committed to reducing plastic consumption and other tourism initiatives to meet the international goals set out in the United Nations’ recommended Sustainable Development Goals (SDGs).

The Zeavola Resort has long been a pioneer in the field of sustainable tourism in Thailand, and has received numerous media articles and hotel awards for its environmentally friendly management approach.

*Article: Zeavola Resort wins three consecutive hotel awards in one month (2019)

https://www.carrushome.com/en/zeavola-resort-in-thailand-wins-three-awards-in-a-month/

https://latteluxurynews.com/2019/11/12/zeavola-resort-scoops-suite-of-awards/

Reflecting these efforts, Zeavola became one of the first hotels in Thailand to join the scheme. Many hotels have since joined the scheme, and Zeavola Resort was featured on the UNESCO website as a member hotel.

(https://unescosustainable.travel/en/zeavola-resort)

Zeavola Resort is now accepting bookings through its own website as well as through all major hotel booking websites, and is offering attractive packages to domestic visitors in line with the current Thai tourism market. For more information, please visit the following websites

Zeavola Resort’s official website: https://www.zeavola.com/

Wedge Holdings Co., Ltd

Contact PIC: Yasuhiro Kotake

TEL: +81-3-6225-2207

KEYWORDS: Thailand Japan Asia Pacific

INDUSTRY KEYWORDS: Environment Vacation Lodging Destinations Travel

MEDIA:

Logo
Logo

Idemitsu invests in European Open Innovation Venture Capital Fund from Emerald

Idemitsu invests in European Open Innovation Venture Capital Fund from Emerald

 

TOKYO–(BUSINESS WIRE)–Idemitsu Kosan Co.,Ltd. (Headquarters: Tokyo, Japan), has decided to invest in an open innovation evergreen fund, managed by Emerald Technology Ventures, a Swiss clean technology-focused venture capital organization (Headquarters: Zurich, Switzerland). In addition, Idemitsu has decided to establish a new open innovation promotion base in Switzerland. For new business creation, Idemitsu strengthens its efforts to accelerate innovations with start-up companies, not only in Japan, but around the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201115005016/en/

The Emerald fund portfolio focuses on industrial innovations in both material chemistry and clean technologies that can help resolve social issues with improvements to energy efficiencies and reductions in carbon dioxide levels. Idemitsu’s investment in this evergreen fund and the creation of a partnership with Emerald will realize new synergies that play on Emerald’s technological expertise and market insight, as well as Emerald’s access to start-up companies in North America, Europe and Israel, together with Idemitsu’s existing technologies and cultivated business networks. Those synergies will in turn lead to the creation of a resilient business portfolio that can flexibly and tenaciously respond to changes in business conditions by incorporating technological innovations from start-up companies.

To further accelerate global open innovations, Idemitsu also plans to establish a European open innovation promotion base in the Swiss canton of Basel-Stadt.

“To resolve the priority themes in our Medium-term Management Plan*, we not only pursue maximal synergies with technologies that are related to those our corporate group has already developed, but will also stress the promotion of open innovations that build on external technologies and ideas,” said Hajime Nakamoto, Managing Executive Officer in Innovation Strategy Planning, Electronic Materials Business, Agri-Bio Business, Lithium Battery Material, Intellectual Property, and Research at Idemitsu. “This investment and the establishment of overseas bases are momentous steps forward for us. Though implementation of open innovation is a long-term objective, we, especially our young employees, drive ourselves forward to laying the foundations early.”

Idemitsu is taking on the challenge of creating new values through the promotion of global open innovation.

Notes:

* Idemitsu’s Medium-term Management Plan (FY2020-2022)

https://sustainability.idemitsu.com/en/themes/259

[Overview of Idemitsu Kosan Co.,Ltd.]

Company Name

Idemitsu Kosan Co.,Ltd.

Business Description

Sustainable supply of various forms of energy and materials

Website

www.idemitsu.com/index.html

[Overview of Emerald Technology Ventures]

Company Name

Emerald Technology Ventures

Business Description

Open Innovation Venture Capital

Website

www.emerald-ventures.com

 

Public Relations Section, Idemitsu Kosan Co., Ltd.

https://www.idemitsu.com/contact/flow/index.html

Yuuka Sakata (Ms.)

[email protected]

KEYWORDS: Australia Australia/Oceania Japan United States Switzerland North America Asia Pacific Israel Europe Middle East India Canada

INDUSTRY KEYWORDS: Professional Services Other Energy Small Business Oil/Gas Energy Finance

MEDIA:

Logo
Logo
Logo
Logo